Aobin Fu – Trademark Portfolio

Entity Type: 01

Aobin Fu holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include ASDRAW and OWNSEX. The owner is based in Yiyang , Hunan.

No.1 Daheba Villager Group, Xuefengshan

Village, Huishangang Town, Taojiang

Yiyang , Hunan 413414 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

OWNSEX
OWNSEX
Registered 2021
ASDRAW
ASDRAW
Registered 2021

Trademark Classifications

Aobin Fu's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Aobin Fu have?

Aobin Fu has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Aobin Fu file in?

Aobin Fu files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are Aobin Fu's most well-known trademarks?

Aobin Fu's registered trademark portfolio includes well-known marks such as ASDRAW and OWNSEX. These are among 2 currently registered trademarks in the portfolio.

What is Aobin Fu's trademark registration success rate?

Aobin Fu has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.